Skip to main content
. Author manuscript; available in PMC: 2021 Sep 12.
Published in final edited form as: Ann Surg Oncol. 2019 Dec 6;27(6):1877–1888. doi: 10.1245/s10434-019-08073-5

Table 1.

Clinical Characteristics

Variable Total (%) Non-Obese (%) Obese (%) p
No. Cases 404 244 160
Timing of Reconstruction 0.29
 Immediate 252 (62.4) 149 (61.1) 103 (64.4)
 Delayed 152 (37.6) 95 (38.9) 57 (35.6)
Flap Type 0.03*
 msTRAM 170 (42.1) 93 (38.1) 77 (48.1)
 Perforator 234(57.9) 151 (61.9) 83 (51.9)
Mastectomy Type
 Skin-Sparing 218 (54.0) 128 (52.5) 90 (56.3) 0.77
 Nipple-Sparing 12 (3.0) 8 (3.3) 4 (2.5) 0.48
Pre-operative Breast Size†† 0.03*
 Small 175 (43.3) 136 (55.7) 39 (24.4)
 Medium 125 (30.9) 57 (23.3) 68 (42.5)
 Large 14(3.5) 5 (2.0) 9 (5.6)
Mean Age ± SD (yr) 50.1 ± 7.9 50.7 ± 8.0 49.2 ± 7.6 0.06
Laterality 0.14
 Unilateral 234 (57.9) 147 (60.2) 87 (54.4)
 Bilateral 170 (42.1) 97 (39.8) 73 (45.6)
Adjuvant Chemotherapy 131 (32.4) 93 (38.1) 38 (23.8) 0.02*
Pre-operative Radiation 124(30.7) 77 (31.6) 47 (29.4) 0.36
History of Smoking 45 (11.1) 19 (7.8) 26 (16.3) 0.01*
Diabetes 119 (29.5) 65 (26.6) 54 (33.8) 0.08
Hypertension 61 (15.1) 38 (15.6) 23 (14.4) 0.43
Hyperlipidemia 61 (15.1) 41 (16.8) 20 (12.5) 0.15
Contralateral Balancing Procedure 96 (23.8) 58 (23.8) 38 (23.8) 0.55
Charlson Comorbidity Scale 2.9 ± 1.2 2.9 ±1.1 2.9 ±1.3 0.62
*

Statistically significant (p < 0.05).

Mastectomy type data unavailable for 174 patients. Percentages are reflective of available patient data (n = 230).

††

Pre-operative breast size data unavailable for 90 patients. Percentages are reflective of available patient data (n = 314).